Peptides Clarified

GLP-1 & metabolic

Compounded semaglutide

Also known as: compounded GLP-1, custom-made semaglutide

Plain-language summary

Semaglutide prepared by compounding pharmacies rather than the FDA-approved manufacturer. The molecule may be the same, but these specific products are not FDA-reviewed or approved.

Regulatory status

Compounded and unapproved products are not FDA-reviewed for safety, effectiveness, or quality.

Evidence snapshot

Insufficient. There is not enough credible human evidence to draw a conclusion for the use described.

How it works

If it contains genuine semaglutide, the mechanism is the same GLP-1 receptor agonism as approved products; however, purity, actual content, and salt form are not guaranteed.

Approved uses and researched uses

FDA-approved uses

None. This product has no FDA-approved use for the context described.

Researched (not approved) uses

  • Weight loss and diabetes management (as unregulated substitutes for approved products)

Researched uses are studied but not FDA-approved and may be off-label. This is not a recommendation to use them.

Known risks and uncertainties

In addition to the known GI and pancreatic risks of semaglutide, the FDA has received adverse-event reports tied to compounded GLP-1s, including dosing errors from patient self-measurement, use of unapproved salt forms, contamination, and hospitalizations. Some marketed products are counterfeit.

Cautions and contraindications

Same clinical contraindications as semaglutide (thyroid C-cell tumor history, MEN 2), plus the added uncertainty that the actual contents and dose may not match the label.

Consumer considerations

  • These products are not FDA-approved and are not reviewed for safety, quality, or potency.
  • Vials requiring self-measurement create a real risk of overdosing.
  • Some online sellers use false labels or nonexistent pharmacy names.
  • Availability often increased during brand shortages, but that does not make them FDA-verified.
  • An FDA-approved brand product is the way to get a reviewed formulation.

Questions to ask a licensed clinician

  • Why is a compounded version being recommended instead of an FDA-approved product?
  • What pharmacy is compounding it and is it state-licensed and reputable?
  • How do I measure and inject the correct dose safely?
  • What are the warning signs of an overdose or contamination reaction?
  • Would an approved brand product be accessible or affordable for me instead?

Sources

Primary and authoritative sources

  1. 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
  2. 2.FDA Warns Telehealth Companies Against Illegal Marketing of Compounded GLP-1s U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
Last reviewed (yesterday)

Reviewed by Peptides Clarified Editorial — Editorial sourcing review — licensed clinical review pending.